Your Browser is Not Supported. Please Update Browser to the Latest Version.
Earlybird Registration Now
With cases of Covid-19 reaching new heights in the world, some states have to adapt rapidly with their rules and regulations. After seeking advice from the some agency and venue hotel in Seoul, also considering the traffic control and epidemic prevention, the committee must admit this August is not a good time for holding an event. So after serious consideration, the organizing committee decides to postpone this meeting to next Oct. 19-21 at Seoul, South Korea. Sincerely hope you can understand such a demanded action.
Apart from protecting our participants, rescheduling non-essential gathering and travel also aims to contain the spread of coronavirus disease and protect the health system which will otherwise be overwhelmed. Thank you very much for your understanding in the complex situation.
Renowned Speakers of Previous Events
Dr. Vladimir Khavinson,
Professor and Director of Saint Petersburg Institute of Bio regulation and
Dr. Andrew A. Potter,
Director& CEO, VIDO-InterVac
Dr. Krishna Dronamraju,
President, Foundation for Genetic Research
Dr. Michael D. West,
Chief Executive Officer, AgeX Therapeutics, Inc.
Dr. Torsten Hoffmann
Chief Operating Officer & Senior VP, Silence Therapeutics
Dr. William Rice
Chairman, President and CEO, Aptose Biosciences Inc.
Professor & Vice Chair, University of Pennsylvania
Dr. Weiqiang Zhao
Associate Professor, The Ohio State University
Dr. Irene Caesar
CEO, Matrix City LLC, Russia; President, Wave Genome LLC
Dr. Lingwen Zeng
Director, Institute of Environment and Safety, Wuhan Academy of
Dr. Jeffrey LBennetzen
Professor, Anhui Agricultural University, China; University of Georgia
Dr. Sushanta K. Mitra
Professor, York University; Executive Director, Waterloo Institute for
Dr. Stefan Gluck
Vice President, Celgene Corporation
Dr. Philipp Kapranov
Professor & Director, HuaQiao University
Professor & Endowed Chair, University of Louisville
Dr. Bruce D. Given
Chief Operating Officer, Arrowhead Pharmaceuticals, Inc.
Introduction to Seoul